Olenxa (Olanzapine)

Olanzapine, the active ingredient in Olenxa, is an atypical antipsychotic presented as a strength/form for oral use. It treats schizophrenia and bipolar I disorder in adults and adolescents. GNH USA supplies Olenxa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olenxa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olenxa is an atypical antipsychotic that acts on dopamine and serotonin pathways to manage serious mental health conditions.

- Schizophrenia: reduces positive and negative symptoms and helps maintain stability. - Bipolar I disorder: controls manic episodes and supports mood stabilization. - Psychotic depression: alleviates depressive symptoms with psychotic features. - Tourette syndrome: lessens the frequency and intensity of motor and vocal tics. - Agitation associated with schizophrenia: provides rapid calming calm. - Chronic ​     ​  ​  ​ ​  ​  ​ ​  ​  ​  ​  ​